Purchase Order HHSN302201600074P

<p>The National Human Genome Research Institute issued a purchase order to Tecan Genomics, Inc. on August 30, 2017, for $5,476.00 under firm fixed-price terms. Performance will take place in North Bethesda, Maryland, with an ultimate completion date of September 30, 2017. No set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Tecan Genomics, Inc. for $16,491.00 on December 2, 2020, for tissue and material, with an ultimate completion date of January 1, 2021. Performance is in North Bethesda, Maryland. No small business set-aside was applied to this firm fixed-price order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,551.24 on January 30, 2018, with an ultimate completion date of February 21, 2019. The order covers laboratory instrumentation, reagents, and consumables. Place of performance is Bethesda, Maryland. The contract carries firm fixed price and no small business set-aside designation.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Tecan Genomics, Inc. valued at $7,823.10 on June 20, 2017, with an ultimate completion date of July 17, 2017. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The specific scope of goods or services procured is not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

The National Human Genome Research Institute (NHGRI) awarded a firm fixed-price purchase order valued at $44,344 to Tecan U.S., Inc. for a service agreement supporting a Tecan Fluent 780 Robot. The contract was awarded on December 27, 2025, with an ultimate completion date of December 26, 2026, and will be performed in Morrisville, North Carolina. This procurement does not utilize a small business set-aside designation, allowing Tecan to compete on an open, unrestricted basis. The award...

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $11,980.00 on August 24, 2017, with completion by September 22, 2017. Performance occurs in Bethesda, Maryland. The order procures laboratory supplies and equipment on a firm fixed-price basis with no set-aside designation.</p>